DEA Addresses Telemedicine Prescribing of Controlled Substances
The use of telemedicine to prescribe controlled substances has seen a dramatic increase in recent years, accelerated by the COVID-19 pandemic and subsequent temporary flexibilities in regulations. The future of these practices hinges on proposed regulations that aim to create a more permanent framework. On January 15, 2025, the U.S. Read more